Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $3,745 | 1 | 66.6% |
| Travel and Lodging | $1,127 | 3 | 20.0% |
| Food and Beverage | $754.64 | 5 | 13.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $5,312 | 5 | $0 (2017) |
| Stryker Corporation | $155.33 | 1 | $0 (2022) |
| Alnylam Pharmaceuticals Inc. | $125.01 | 1 | $0 (2024) |
| W. L. Gore & Associates, Inc. | $19.69 | 1 | $0 (2017) |
| CSL Behring | $14.59 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $125.01 | 1 | Alnylam Pharmaceuticals Inc. ($125.01) |
| 2022 | $155.33 | 1 | Stryker Corporation ($155.33) |
| 2017 | $5,346 | 7 | PFIZER INC. ($5,312) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/15/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $125.01 | General |
| Category: Genetic Disease | ||||||
| 06/22/2022 | Stryker Corporation | SPY-PHI SYSTEM (Device) | Food and Beverage | In-kind items and services | $155.33 | General |
| Category: ENDOSCOPY | ||||||
| 09/01/2017 | PFIZER INC. | — | Travel and Lodging | In-kind items and services | $128.14 | General |
| 08/17/2017 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $3,745.00 | General |
| 06/27/2017 | PFIZER INC. | — | Travel and Lodging | In-kind items and services | $745.96 | General |
| 06/27/2017 | PFIZER INC. | — | Food and Beverage | In-kind items and services | $440.02 | General |
| 06/27/2017 | PFIZER INC. | — | Travel and Lodging | In-kind items and services | $252.95 | General |
| 03/24/2017 | W. L. Gore & Associates, Inc. | VIABAHN Endoprosthesis with Heparin Bioactive Surface (Device) | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: Devices | ||||||
| 02/08/2017 | CSL Behring | Kcentra (Biological) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: Critical Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 238 | 263 | $36,970 | $23,346 |
| 2022 | 10 | 860 | 1,112 | $139,487 | $95,320 |
| 2021 | 15 | 997 | 1,247 | $146,767 | $103,236 |
| 2020 | 11 | 683 | 731 | $106,956 | $56,067 |
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 44 | 45 | $10,035 | $6,534 | 65.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 37 | 44 | $7,746 | $4,660 | 60.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 26 | 27 | $7,749 | $4,575 | 59.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 27 | 28 | $3,337 | $1,756 | 52.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 20 | 20 | $2,920 | $1,755 | 60.1% |
| 91322 | Sarscov2 vac 50 mcg/0.5ml im | Office | 2023 | 12 | 12 | $1,800 | $1,716 | 95.3% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 38 | 40 | $2,280 | $1,406 | 61.7% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 12 | 12 | $480.00 | $470.40 | 98.0% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 11 | 23 | $483.00 | $381.78 | 79.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 11 | 12 | $139.80 | $91.32 | 65.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 335 | 441 | $73,759 | $47,713 | 64.7% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 263 | 403 | $22,815 | $14,152 | 62.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 78 | 78 | $17,394 | $13,852 | 79.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 56 | 57 | $8,322 | $6,947 | 83.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 31 | 32 | $7,456 | $5,966 | 80.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 18 | 18 | $5,166 | $4,226 | 81.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 20 | 24 | $2,832 | $2,101 | 74.2% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 23 | 23 | $1,035 | $177.44 | 17.1% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2022 | 24 | 24 | $288.00 | $102.49 | 35.6% |
| 71045 | X-ray of chest, 1 view | Office | 2022 | 12 | 12 | $420.00 | $82.76 | 19.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 358 | 466 | $74,237 | $53,466 | 72.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 107 | 107 | $23,827 | $19,164 | 80.4% |
| 87426 | Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 200 | 312 | $17,572 | $11,008 | 62.6% |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | Office | 2021 | 12 | 12 | $6,600 | $5,388 | 81.6% |
| 86328 | Test for detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antibody, qualitative or semiquantitative | Office | 2021 | 57 | 81 | $8,100 | $3,664 | 45.2% |
About Dr. Richard Watson, MD
Dr. Richard Watson, MD is a Emergency Medicine healthcare provider based in Chicago Heights, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1962472886.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Watson, MD has received a total of $5,627 in payments from pharmaceutical and medical device companies, with $125.01 received in 2024. These payments were reported across 9 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($3,745).
As a Medicare-enrolled provider, Watson has provided services to 2,778 Medicare beneficiaries, totaling 3,353 services with total Medicare billing of $277,969. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Practice Information
- Specialty Emergency Medicine
- Location Chicago Heights, IL
- Active Since 01/24/2006
- Last Updated 09/13/2018
- Taxonomy Code 207P00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1962472886
Products in Payments
- SPY-PHI SYSTEM (Device) $155.33
- AMVUTTRA (Drug) $125.01
- VIABAHN Endoprosthesis with Heparin Bioactive Surface (Device) $19.69
- Kcentra (Biological) $14.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Chicago Heights
Sophie Simeakis, Do, DO
Emergency Medicine — Payments: $582.81
Dr. Briana Young, Md, MD
Emergency Medicine — Payments: $465.11
Dr. Edwin Hinton, D.o, D.O
Emergency Medicine — Payments: $121.06
Dr. Gregory Olmsted, M.d, M.D
Emergency Medicine — Payments: $109.40
Jarrod Barker, M.d, M.D
Emergency Medicine — Payments: $66.85
Sandra Grochowski, Md, MD
Emergency Medicine — Payments: $43.58